Orion Pharma Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	172.89	72.1	147.73	130.11	106.13	414.99
Short-Term Investments	65.29	54.18	45.82	38.68	31.83	23.62
Cash & Short-Term Investments	238.18	126.28	193.55	168.79	137.97	438.61
Cash Growth	60.65%	-34.75%	14.67%	22.34%	-68.54%	-58.38%
Accounts Receivable	4,290	4,390	4,210	5,584	6,796	3,943
Other Receivables	10,660	10,656	10,267	9,811	8,109	8,458
Receivables	14,950	15,046	14,477	15,395	14,905	12,401
Inventory	1,364	1,505	1,699	1,614	1,660	1,411
Prepaid Expenses	-	-	0.11	1.1	26.19	43.84
Other Current Assets	910.82	859.62	1,045	1,897	2,026	1,928
Total Current Assets	17,464	17,537	17,415	19,076	18,755	16,223
Property, Plant & Equipment	31,994	30,937	28,951	26,424	23,009	19,856
Long-Term Investments	7,446	7,322	8,067	7,440	6,343	6,254
Other Long-Term Assets	0	-	-	-	-	-
Total Assets	56,904	55,796	54,433	52,940	48,107	42,333
Accounts Payable	5,589	6,710	6,136	6,259	7,301	4,231
Accrued Expenses	295.77	278.28	298.44	270.03	265.44	232.48
Short-Term Debt	412.09	493.7	556.18	547.82	563.9	564.32
Current Portion of Long-Term Debt	-	-	67.35	490.5	387.47	274.33
Current Portion of Leases	11.54	14.93	13.94	23.91	31.66	36.42
Current Income Taxes Payable	330.44	321.16	304.49	435.26	398.62	262.75
Other Current Liabilities	1,855	645.99	390.05	1,444	488.23	406.06
Total Current Liabilities	8,494	8,464	7,766	9,470	9,437	6,008
Long-Term Debt	26,295	25,137	23,111	20,808	17,601	15,930
Long-Term Leases	28.54	31.69	13.71	26.35	35.27	39.9
Long-Term Deferred Tax Liabilities	434.68	402.12	315.43	157.7	122.25	138.28
Other Long-Term Liabilities	143.41	143.41	143.41	143.41	143.41	143.41
Total Liabilities	35,395	34,178	31,350	30,606	27,338	22,259
Common Stock	2,340	2,340	2,340	2,340	2,340	2,340
Additional Paid-In Capital	8,017	8,017	8,017	8,017	8,017	8,017
Retained Earnings	6,658	6,857	7,499	7,400	6,978	6,401
Comprehensive Income & Other	3,049	2,932	3,683	3,067	1,978	1,905
Total Common Equity	20,064	20,146	21,540	20,824	19,313	18,663
Minority Interest	1,445	1,472	1,543	1,510	1,456	1,412
Shareholders' Equity	21,509	21,618	23,083	22,334	20,769	20,074
Total Liabilities & Equity	56,904	55,796	54,433	52,940	48,107	42,333
Total Debt	26,747	25,677	23,762	21,897	18,619	16,844
Net Cash (Debt)	-26,497	-25,539	-23,552	-21,700	-18,446	-16,377
Net Cash Per Share	-113.23	-109.14	-100.65	-92.74	-78.83	-69.99
Filing Date Shares Outstanding	234	234	234	234	234	234
Total Common Shares Outstanding	234	234	234	234	234	234
Working Capital	8,970	9,073	9,648	9,606	9,318	10,216
Book Value Per Share	85.74	86.09	92.05	88.99	82.53	79.76
Tangible Book Value	20,064	20,146	21,540	20,824	19,313	18,663
Tangible Book Value Per Share	85.74	86.09	92.05	88.99	82.53	79.76

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.